Rotterdam

• Stopping or continuing blood thinners after stroke at young age without a known cause: STOP trial Recruiting
  2024-513092-40-00 6 2024-12-05 Stroke
• Protecting late-moderate preterm infants from respiratory tract infections and wheeze in their first year of life by using bacterial lysates Recruiting
  2024-518498-32-01 5 2024-12-05 Lower respiratory tract infections and wheezing in moderate-late prema
• This is a study to evaluate safety and efficacy of Upadacitinib comparing to Dupilumab in children from 2 to less than 12 years of age with … Recruiting
  2023-504713-76-00 5 2024-12-03 Dermatitis atopic
• Tolerogenic dendritic cell therapy in type 1 diabetes; a phase 1b safety and immunological effecitivity study Recruiting
  2023-508558-25-01 9 2024-12-02 Type 1 Diabetes
• The effect of [18F]F-FAPI PET-CT on management in patients with potentially resectable biliary tract cancers: prospective multicenter study … Recruiting
  2023-507938-24-00 5 2024-11-29 Cholangiocarcinoma
• MAGE-C2 TCR T cell therapy Recruiting
  2024-516922-70-00 9 2024-11-29 advanced melanoma or HNSCC
• Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104 (HEB-PEP) Recruiting
  2024-518355-36-01 1 2024-11-27 chronic Hepatitis B
• The PREDMETH trial: Effectiveness of methotrexate versus prednisone as first-line therapy for pulmonary sarcoidosis – A randomized controlle … Recruiting
  2024-514055-15-00 6 2024-11-19 Pulmonary sarcoidosis
• A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-fibrosis) Recruiting
  2023-509912-27-00 5 2024-11-07 Metabolic Dysfunction-Associated Steatotic Liver Disease(MASH) / Nonal
• A rollover study of avapritinib (also called BLU-285) in adults Who Participated in a Previous Avapritinib Study Recruiting
  2024-514969-18-00 6 2024-11-05 Systemic Mastocytosis
• Preoperative amivantamab or amivantamab and carboplatin/pemetrexed treatment in patients with resectable non-small-cell lung cancer harborin … Recruiting
  2023-505662-28-00 4 2024-10-30 Non-small-cell lung cancer stages I B, II and selected stages III A an
• Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH (ENLIGHTEN-Cirrhosis) Recruiting
  2023-510395-31-00 5 2024-10-30 Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Compensat
• A phase 3 trial comparing a therapeutic cancer vaccine OSE2101 to chemotherapy docetaxel in patients with metastatic Non-Small Cell Lung Can … Recruiting
  2023-509340-10-00 5 2024-10-29 Patients with HLA-A2 positive phenotype and metastatic Non-Small Cell
• CHASIT Recruiting
  2024-516940-24-00 4 2024-10-29 locally advanced urothelial cancer.
• Timing of start of systemlc treatment for asymptomatic MEtastasized PANcreatic cancer (TIMEPAN): a prospective multicenter patient preferenc … Recruiting
  2023-509465-20-00 5 2024-10-28 metastatic pancreatic cancer
• DAROTAXEL Recruiting
  2024-516939-28-00 4 2024-10-28 metastatic castration-resistant prostate cancer
• Preventing liver recurrence after partial hepatectomy for intrahepatic cholangiocarcinoma using adjuvant hepatic arterial infusion pump chem … Recruiting
  2024-513726-33-00 4 2024-10-25 Intrahepatic cholangiocarcinoma (iCCA)
• Local Levobupivacaine for pain reflief after esophageal ESD Recruiting
  2024-510912-66-00 6 2024-10-22 Visible esophageal lesions ((pre)cancerous)
• A study to test whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure. Recruiting
  2023-509706-30-00 5 2024-10-18 Heart failure (HF)
• PERi-operative Selective Decontamination of the Digestive tract to prevent severe infectious complications after Esophagectomy: a Randomized … Recruiting
  2023-504144-33-01 11 2024-10-17 esophageal cancer
• Safety and efficacy of avalglucosidase alfa in patients with non-classic Pompe disease aged ≥ 5 years. Recruiting
  2024-518215-18-00 6 2024-10-16 Glycogen storage disease type II or acid maltase deficiency, Pompe dis
• DOSAgE study: A multicenter randomized phase III trial of DOSe-reduced Chemotherapy for Advanced Colorectal Cancer in Older patients Recruiting
  2023-506115-17-00 5 2024-10-14 Metastatic Colorectal Cancer
• Can we Save the rectum by watchful waiting or transanal surgery following short- or long-course radioTherapy and Additional local oR systemi … Recruiting
  2024-514620-17-00 4 2024-10-14 Patients with early-stage rectal cancer (defined as early rectal cance
• TAP-TAU Recruiting
  2023-505430-10-00 10 2024-10-10 Mild cognitive impairment and dementia

Showing 289–312 of 818 trials